Research

Dr. Susan Love Research Foundation would like to extend heartfelt congratulations to Leah Eshraghi and Amaka Obidegwu, who were recently promoted to research director and research project manager, respectively.

PROMPT was created by cancer researchers at Dana Farber Cancer Institute, Mayo Clinic, Memorial Sloan Kettering Cancer Center, and the University of Pennsylvania. The mission of PROMPT is simple—to create a way for participants to provide critical information to help promote scientific discoveries related to cancer susceptibility genes. By taking part in PROMPT, participants can also learn more about how genetic alterations in certain genes may affect their health and cancer risk, while helping researchers to better understand these risks.

Cancer cells are not loners. They communicate with each other, with the other cells in their neighborhood, and with cells in the entire universe of your body. Now, a flurry of basic research has led to new insights into this communication and an exciting new realm of investigation.

Dear Friends,

Dr. Susan Love Research Foundation is, as you likely know by now, dedicated to a future without breast cancer. For us, that means conducting research into the cause of breast cancer so we can learn how to stop it before it starts. This isn’t a popular area of research. Cure is much sexier. Cure means you’re fixing people and that makes you a savior.

Much of the discussion and debate about breast cancer is currently over issues like screening guidelines, risk, and prophylactic bilateral mastectomies. This focus on risk reduction and early detection can lull us into a false sense of security, suggesting that if we just do this early stuff right we can prevent all breast cancer deaths. But women and men still die from breast cancer even after screening, bilateral mastectomies, “precision medicine,” and targeted therapy! Why? Because we don’t yet know enough about metastases.